Litcius/Paper detail

Hydroxychloroquine for covid-19: the end of the line?

Elisabeth Mahase

2020BMJ52 citationsDOIOpen Access PDF

Abstract

Controversies and disappointing trial results have dampened excitement about an established drug touted as a “game changer” for the novel coronavirus. <b>Elisabeth Mahase</b> asks what the future now holds for hydroxychloroquine

Topics & Concepts

HydroxychloroquineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusLine (geometry)Coronavirus InfectionsMedicineSecond lineVirologyComputer scienceData scienceFirst lineInternal medicineOutbreakGeometryInfectious disease (medical specialty)MathematicsDiseasePharmacological Receptor Mechanisms and EffectsVitamin C and Antioxidants ResearchDrug-Induced Hepatotoxicity and Protection